• LAST PRICE
    20.2600
  • TODAY'S CHANGE (%)
    Trending Down-0.1000 (-0.4912%)
  • Bid / Lots
    ---/ ---
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    20.4500 / 20.3600
  • Day Range
    Low 19.8500
    High 20.7100
  • 52 Week Range
    Low 13.0700
    High 28.6701
  • Volume
    962,940
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 20.36
TimeVolumeBCYC
09:32 ET45920.71
09:33 ET10020.57
09:35 ET10020.265
09:37 ET10020.0591
09:46 ET30020.3
09:53 ET589820.4
10:02 ET70020.24
10:04 ET27220.2
10:06 ET60020.1
10:08 ET40020
10:09 ET31720.0295
10:13 ET43620.09
10:15 ET10020.11
10:20 ET110020.05
10:24 ET40020.04
10:26 ET55020.03
10:27 ET30020
10:29 ET280020.08
10:31 ET248520.08
10:33 ET70020.08
10:36 ET130020.03
10:38 ET31020.05
10:42 ET169419.95
10:45 ET40010019.965
10:47 ET21020.05
10:49 ET10020.115
10:51 ET162320.11
10:54 ET374220.12
10:56 ET290020.11
10:58 ET50020.1
11:02 ET10020.135
11:03 ET60020.01
11:05 ET30019.95
11:07 ET10019.86
11:09 ET65020
11:12 ET10020.01
11:14 ET50020.055
11:16 ET30020.03
11:18 ET30019.96
11:20 ET50020.2
11:21 ET30020.22
11:23 ET120020.115
11:25 ET20019.99
11:30 ET300520.05
11:32 ET12726920.073
11:34 ET30020.06
11:36 ET50020.1
11:38 ET90020
11:39 ET151019.96
11:41 ET135019.86
11:43 ET20019.85
11:45 ET20019.9
11:48 ET180019.96
11:50 ET20020.02
11:57 ET10019.94
11:59 ET76920
12:01 ET10020
12:06 ET12019.945
12:08 ET113119.98
12:15 ET126519.85
12:17 ET340019.95
12:21 ET168719.95
12:24 ET292920
12:26 ET23119.97
12:28 ET20020
12:30 ET10020.065
12:32 ET110020
12:33 ET173920
12:35 ET399920.02
12:37 ET60020.1
12:39 ET10020.2867
12:42 ET20020.1506
12:44 ET10020.235
12:46 ET30020.13
12:48 ET50020.195
12:50 ET130020.19
12:53 ET698920.05
12:55 ET586320.075
12:57 ET187920.16
01:00 ET571220.1106
01:02 ET250020.11
01:04 ET251020.11
01:06 ET286520.12
01:08 ET620020.035
01:09 ET149320.08
01:11 ET30020.06
01:13 ET80220.105
01:18 ET10020.02
01:20 ET110020.03
01:24 ET10020.02
01:26 ET10019.98
01:27 ET187519.98
01:31 ET40019.99
01:33 ET159320
01:36 ET20020.115
01:38 ET20020
01:40 ET10020
01:42 ET240320.05
01:44 ET44220.11
01:47 ET142220.09
01:51 ET10020.095
01:54 ET160020.05
01:56 ET25020.06
01:58 ET50020.05
02:12 ET80020.05
02:16 ET110020.16
02:21 ET40020.1
02:30 ET10020.12
02:34 ET30020.2
02:36 ET82520.1204
02:38 ET370020.19
02:39 ET10020.185
02:41 ET20020.175
02:43 ET18020.215
02:45 ET27520.18
02:50 ET243720.14
02:52 ET20020.16
02:54 ET10020.15
02:57 ET13020.1601
02:59 ET10020.16
03:06 ET218620.16
03:08 ET39720.19
03:10 ET24820.13
03:17 ET20020.26
03:19 ET1394020.515
03:21 ET60020.43
03:26 ET20020.455
03:28 ET322020.38
03:32 ET17420.36
03:35 ET10020.3741
03:37 ET90820.315
03:42 ET180020.47
03:46 ET69120.345
03:48 ET20020.39
03:50 ET40020.36
03:51 ET102920.385
03:53 ET70020.39
03:55 ET150920.37
03:57 ET73420.235
04:00 ET2064820.26
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesBCYC
Bicycle Therapeutics PLC
1.4B
-6.2x
---
United StatesNTLA
Intellia Therapeutics Inc
1.4B
-2.5x
---
United StatesSYRE
Spyre Therapeutics Inc
1.4B
-3.6x
---
United StatesPRAX
Praxis Precision Medicines Inc
1.4B
-7.1x
---
United StatesDAWN
Day One Biopharmaceuticals Inc
1.3B
-13.1x
---
United StatesSNDX
Syndax Pharmaceuticals Inc
1.3B
-4.3x
---
As of 2024-11-22

Company Information

Bicycle Therapeutics plc is a United Kingdom-based clinical-stage biopharmaceutical company developing a novel class of medicines, referred to as Bicycle molecules, for diseases that are underserved by existing therapeutics. Bicycle molecules are fully synthetic short peptides constrained with small molecule scaffolds to form two loops that stabilize their structural geometry. The Company is evaluating BT8009, a Bicycle Toxin Conjugate (BTC) targeting Nectin-4, a well-validated tumor antigen; BT5528, a BTC targeting EphA2, a historically undruggable target, and BT7480, a Bicycle Tumor-Targeted Immune Cell Agonist (Bicycle TICA) targeting Nectin-4 and agonizing CD137, in Company-sponsored clinical trials. Additionally, the Company is developing Bicycle Radio Conjugates (BRC) for radiopharmaceutical use and, through various partnerships, is exploring the use of Bicycle technology to develop therapies for diseases beyond oncology. Its product candidates also include BT1718 and BT7455.

Contact Information

Headquarters
Blocks A & B, Portway Building, Granta PCAMBRIDGE, United Kingdom CB21 6GS
Phone
122-326-1503
Fax
---

Executives

Non-Executive Chairman of the Board
Pierre Legault
Chief Executive Officer, Executive Director
Kevin Lee
Chief Financial Officer, Principal Financial Officer
Alethia Young
Chief Operating Officer
Alistair Milnes
Chief Technology Officer
Michael Skynner

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$1.4B
Revenue (TTM)
$36.9M
Shares Outstanding
69.0M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.88
EPS
$-3.28
Book Value
$8.74
P/E Ratio
-6.2x
Price/Sales (TTM)
37.9
Price/Cash Flow (TTM)
---
Operating Margin
-534.98%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.